Amgen Inc. (AMGN) earnings
AMGN earnings moved a median of +0.50% by the close. Quarterly and annual AMGN reports and results, each read against the price at its own news timestamp. Back to the AMGN overview →
20 measured AMGN earnings events.
Where these AMGN earnings landedvs 20 measured AMGN earnings reactions
| Middle 50% of AMGN earnings reactions | -2.65% to +1.03% |
|---|---|
| Median reaction (to close) | +0.50% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 AMGN earnings events with a measured close landed between -2.65% and +1.03%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q AMGEN INC For: Jun 30 | SEC filing · Form 10-Q | +5.06% | +3.78% | |
| AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS | Press release | +5.06% | +3.78% | |
| Form 10-Q AMGEN INC For: Mar 31 | SEC filing · Form 10-Q | -0.28% | +0.62% | |
| AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS | Press release | -1.80% | -0.81% | |
| Form 10-K AMGEN INC For: Dec 31 | SEC filing · Form 10-K | -0.36% | +0.67% | |
| Form 10-Q AMGEN INC For: Sep 30 | SEC filing · Form 10-Q | +0.63% | +5.79% | |
| AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS | Press release | +0.63% | +5.79% | |
| Form 10-Q AMGEN INC For: Jun 30 | SEC filing · Form 10-Q | -2.60% | -3.67% | |
| AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS | Press release | -2.60% | -3.67% | |
| Form 10-Q AMGEN INC For: Mar 31 | SEC filing · Form 10-Q | -2.33% | -3.53% | |
| AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS | Press release | -2.33% | -3.53% | |
| Form 10-K AMGEN INC For: Dec 31 | SEC filing · Form 10-K | +0.23% | +0.58% | |
| Form 10-Q AMGEN INC For: Sep 30 | SEC filing · Form 10-Q | +0.69% | +0.78% | |
| AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS | Press release | +0.69% | +0.78% | |
| Form 10-Q AMGEN INC For: Jun 30 | SEC filing · Form 10-Q | -1.86% | -2.65% | |
| AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS | Press release | -1.86% | -2.65% | |
| Form 10-Q AMGEN INC For: Mar 31 | SEC filing · Form 10-Q | +0.41% | -0.63% | |
| AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS | Press release | +0.41% | -0.63% | |
| Form 10-K AMGEN INC For: Dec 31 | SEC filing · Form 10-K | -0.25% | +0.41% | |
| Form 10-Q AMGEN INC For: Sep 30 | SEC filing · Form 10-Q | +0.38% | +1.78% |
Keep exploring
More AMGN: analyst actions → · SEC filings → · AMGN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| INTELLIPHARMACEUTICS (IPCI) | 619 | -0.40% | 39% |
| Neurocrine Biosciences, Inc. (NBIX) | 619 | -0.14% | 42% |
| Jounce Therapeutics, Inc. (JNCE) | 612 | 0.00% | 48% |
| Bausch Health Companies Inc. (BHC) | 610 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.